Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Renal Function and Risk of Arterial Thrombotic Events in Patients Positive for Lupus Anticoagulant

Meaghan Colling, Florian Posch, Silvia Koder, Peter Quehenberger, Cihan Ay, Ingrid Pabinger, Johanna Gebhart

Blood (2021) 138 (Supplement 1): 290.

https://doi.org/10.1182/blood-2021-148365

Published: 2021

Journal Articles

Biomarkers of Haemostasis and Occurrence of Venous Thromboembolism Are Associated with Disease Progression and Poor Prognosis in Patients with Pancreatic Cancer

Florian Moik, MD, Gerald Prager, MD, Sarah Wiedemann, Florian Posch, MD MSc, PhD, Ingrid Pabinger, MD, Cihan Ay, MD

Blood (2020) 136 (Supplement 1): 7–8.

https://doi.org/10.1182/blood-2020-141239

Published: 2020

Journal Articles

The Role of Neutrophil Extracellular Traps in Cancer-Associated Arterial Thrombosis

Ella Grilz, MD, Lisa-Marie Mauracher, MSc, Oliver Königsbrügge, MD PhD, Florian Posch, MD MSc, Irene Lang, MD, Ingrid Pabinger, MD, Cihan Ay, MD

Blood (2018) 132 (Supplement 1): 2508.

https://doi.org/10.1182/blood-2018-99-116104

Published: 2018

Journal Articles

Longitudinal Haemostatic Biomarker Trajectories Predict Cancer-Associated Venous Thromboembolism

Florian Posch, MD MSc, Julia Riedl, MD, Eva-Maria Reitter, MD, Peter Quehenberger, MD, Cihan Ay, MD, Ingrid Pabinger, MD

Blood (2017) 130 (Supplement 1): 1095.

https://doi.org/10.1182/blood.V130.Suppl_1.1095.1095

Published: 2017

Journal Articles

Podoplanin expression in primary brain tumors induces platelet aggregation and increases risk of venous thromboembolism

Julia Riedl, Matthias Preusser, Pegah Mir Seyed Nazari, Florian Posch, Simon Panzer, Christine Marosi, Peter Birner, Johannes Thaler, Christine Brostjan, Daniela Lötsch, Walter Berger, Johannes A. Hainfellner, Ingrid Pabinger, Cihan Ay

Blood (2017) 129 (13): 1831–1839.

https://doi.org/10.1182/blood-2016-06-720714

Published: 2017

Includes: Supplemental data

Journal Articles

Annexin A5 Resistance Is Associated with Thrombotic Risk in Patients with the Lupus Anticoagulant: The Vienna Lupus Anticoagulant and Thrombosis Study (LATS)

Florian Posch, MDMSc, Johanna Gebhart, MD, Wu Xiao-Xuan, PhD, Silvia Koder, Cihan Ay, MD, Jacob H. Rand, MD, Ingrid Pabinger, MD

Blood (2015) 126 (23): 3555.

https://doi.org/10.1182/blood.V126.23.3555.3555

Published: 2015

Journal Articles

Thrombotic Events in Lupus Anticoagulant Positive Patients Prospectively Correlate with Clinical Risk Factors - the Vienna Lupus Anticoagulant and Thrombosis Study (LATS)

Florian Posch, MDMSc, Johanna Gebhart, MD, Jacob H. Rand, MD, Bas de Laat, MDPhD, Silvia Koder, Peter Quehenberger, MD, Cihan Ay, Ingrid Pabinger, MD

Blood (2015) 126 (23): 652.

https://doi.org/10.1182/blood.V126.23.652.652

Published: 2015

Journal Articles

Prediction of Venous Thromboembolism in Patients with Cancer By the Activated Partial Thromboplastin Time: Results from the Vienna Cancer and Thrombosis Study

Cihan Ay, MD, Florian Posch, MDMSc, Julia Riedl, MD, Oliver Koenigsbruegge, MD, Peter Quehenberger, MD, Christoph Zielinski, MD, Ingrid Pabinger, MD

Blood (2015) 126 (23): 653.

https://doi.org/10.1182/blood.V126.23.653.653

Published: 2015

Journal Articles

Increased mortality in patients with the lupus anticoagulant: the Vienna Lupus Anticoagulant and Thrombosis Study (LATS)

Johanna Gebhart, Florian Posch, Silvia Koder, Thomas Perkmann, Peter Quehenberger, Claudia Zoghlami, Cihan Ay, Ingrid Pabinger

Blood (2015) 125 (22): 3477–3483.

https://doi.org/10.1182/blood-2014-11-611129

Published: 2015

Journal Articles

Red Cell Distribution Width and Other Red Blood Cell Parameters in Patients with Cancer: Association with Risk of Venous Thromboembolism and Mortality

Julia Riedl, Florian Posch, Eva-Maria Reitter, Ernst Eigenbauer, Christine Marosi, Ilse Schwarzinger, Christoph Zielinski, Ingrid Pabinger, Cihan Ay, MD

Blood (2014) 124 (21): 2859.

https://doi.org/10.1182/blood.V124.21.2859.2859

Published: 2014

NARROW

Renal Function and Risk of Arterial Thrombotic Events in Patients Positive for Lupus Anticoagulant

Biomarkers of Haemostasis and Occurrence of Venous Thromboembolism Are Associated with Disease Progression and Poor Prognosis in Patients with Pancreatic Cancer

The Role of Neutrophil Extracellular Traps in Cancer-Associated Arterial Thrombosis

Longitudinal Haemostatic Biomarker Trajectories Predict Cancer-Associated Venous Thromboembolism

Podoplanin expression in primary brain tumors induces platelet aggregation and increases risk of venous thromboembolism

Annexin A5 Resistance Is Associated with Thrombotic Risk in Patients with the Lupus Anticoagulant: The Vienna Lupus Anticoagulant and Thrombosis Study (LATS)

Thrombotic Events in Lupus Anticoagulant Positive Patients Prospectively Correlate with Clinical Risk Factors - the Vienna Lupus Anticoagulant and Thrombosis Study (LATS)

Prediction of Venous Thromboembolism in Patients with Cancer By the Activated Partial Thromboplastin Time: Results from the Vienna Cancer and Thrombosis Study

Increased mortality in patients with the lupus anticoagulant: the Vienna Lupus Anticoagulant and Thrombosis Study (LATS)

Red Cell Distribution Width and Other Red Blood Cell Parameters in Patients with Cancer: Association with Risk of Venous Thromboembolism and Mortality

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only